Abstract
Synthesis and structure-activity relationships (SAR) of arginine vasopressin receptor (AVP) antagonists are described. Potent and orally active compounds are prepared when tricyclic 10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine moiety in VPA-985 1 is replaced with a compound 7 or 12.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Animals
-
Antidiuretic Hormone Receptor Antagonists*
-
Azepines / chemical synthesis*
-
Azepines / pharmacology*
-
Benzamides / chemical synthesis*
-
Benzamides / pharmacology*
-
Benzazepines / chemical synthesis*
-
Benzazepines / pharmacology
-
Fibroblasts
-
Inhibitory Concentration 50
-
Mice
-
Pyrroles
-
Structure-Activity Relationship
-
Thiophenes / chemical synthesis*
-
Thiophenes / pharmacology
Substances
-
5-(((2-chloro-4-(5-fluoro-2-methylphenyl)carbonylamino)phenyl)carbonyl)-9,10-dihydro-4H-thieno(2,3-c)(1)benzazepine
-
5-((4-((2-methylphenyl)carbonylamino)phenyl)carbonyl)-4,10-dhydro-5H-thieno(3,2-c)(1)benzazepine
-
Antidiuretic Hormone Receptor Antagonists
-
Azepines
-
Benzamides
-
Benzazepines
-
Pyrroles
-
Thiophenes
-
lixivaptan